ARTICLE | Company News
Agenus, Merck deal
May 5, 2014 7:00 AM UTC
Agenus will use its 4-Antibody Retrocyte Display antibody platform to discover human antibodies against two undisclosed immune checkpoint targets from Merck to treat cancer. Agenus will be responsible...